Screening mamario.
Controversias
Palabras clave:
screening mamario, cribado, póster, seramResumen
Objetivos Docentes
El objetivo de esta revisión es analizar las críticas surgidas en los últimos años al cribado poblacional del cáncer de mama, haciendo un repaso histórico tanto de los argumentos a favor como en contra del mismo.
Revisión del tema
UN POCO DE HISTORIA
Wilhelm Conrad Röntgen, físico alemán, trabajando con un tubo de rayos catódicos, descubre los rayos X de manera accidental el 8 de Noviembre de 1895. Este hallazgo le valió el premio Nobel de Física en 1901.
A partir de ahí, se conocen varios médicos con especial atención a la radiología mamaria. Entre ellos destaca Albert Salomon, el cual, también en Alemania, hizo un estudio radiológico sobre 3000 piezas de mastectomía, siendo el primero que describe distintos tipos de carcinoma mamario y su diseminación ganglionar, fundamentalmente a región axilar.
Descargas
Citas
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011;61:409-18.
Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6:CD001877.
Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283:2975-8.
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ 2014;348:g366.
Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
The Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. 2012. www.cancerresearchuk.org/sites/default/files/breast-screening-review-exec_0.pdf.
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367:1998-2005.
Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
Fletcher SW, Elmore JG. Mammographicscreening for breast cancer. N Engl J Med 2003;348:1672-80. Woolf SH. The 2009 Breast Cancer Screening Recommendations of the US Preventive Services Task Force. JAMA 2010; 303: 162–63.
Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40–74 years. CMAJ 2011; 183: 1991–2001.
Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260(3):658–663.
Smith RA, Duffy SW, Gabe R, Tabar L,Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;42(5): 793–806, v.
D’Orsi CJ, Sickles EA, Mendelson EB, et al. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, Va: American College of Radiology, 2013. 53.
Sickles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 2010;48(5): 859–878.
Kopans DB . The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn . Radiology 2010 ; 256 ( 1 ): 15 – 20 .
Berg WA . Benefi ts of screening mammography. JAMA 2010 ; 303 ( 2 ): 168 – 169 . Smith RA , Cokkinides V , Brooks D , Saslow D ,Brawley OW . Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening . CA
Cancer J Clin 2010 ; 60 ( 2 ): 99 – 119 .
Kopans DB , Monsees B , Feig SA . Screening for cancer: when is it valid?—Lessons from the mammography experience . Radiology 2003 ; 229 ( 2 ): 319 – 327 .
Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013;310:797-8.
Welch HG, Schwartz L, Woloshin S. Overdiagnosed: Making people sick in the pursuit of health. Boston: Beacon Press; 2011.
Kopans DB. Point: the New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically incorrect and should be withdrawn. J Am Coll Radiol 2013;10: 317-9.
